Algaia and Gelymar to distribute jointly in the U.S. through AIDP as part of new long-term commercial and development agreement
Algaia S.A. and Gelymar S.A. to distribute jointly through AIDP Inc. in the U.S.
Photo © iStockphoto.com
Algaia, S.A. (Paris, France), and Gelymar, S.A. (Santiago, Chile) have a new long-term commercial and development agreement for their strategic partnership. Algaia is a manufacturer of alginates and specialty algae extracts, and Gelymar specializes in the manufacturing of carrageenan. As part of the new agreement, Algaia will continue to represent Gelymar in Europe, and both companies have decided on using a joint commercialization channel in the U.S., marketing their products in the North America region through AIDP Inc. (City of Industry, CA), which currently serves as Algaia’s U.S. distributor. The entire product portfolio of both companies will be available through AIDP, positioning Algaia and Gelymar as leading manufacturers of sustainable algae extracts.
“Gelymar and Algaia remain independent companies in term of equity but both companies share the same ethics, mind-sets and value proposition with their manufacturing facilities being located next to abundant fresh seaweed biomass,” explained Andres Hohlberg, CEO of Gelymar, in a press release. “As we like to say, we both share the same ‘ethiquity’ in the way we serve the market in its evolution toward natural and sustainable sourcing.”
“There are multiple synergies between both companies’ portfolios, and many customers in Europe had already expressed their satisfaction in obtaining both a full range of algae solutions and the proximity of regional R&D facilities and technical-commercial experts ‘speaking their own language,’” said Fabrice Bohin, CEO of Algaia, in a press release. “We have a long history of trustworthy collaboration and both companies share the same obsession for customer satisfaction, sustainable sourcing, waste valorization, environmental protection, CSR, highest industry standards, agility, and innovation spirit. As of now, our US customers will be able to benefit from these synergies as well.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
